{
 "PrintNo":"S2315","Session":2025,"Chamber":"SENATE","BillType":"Senate","Published":"2025-01-16T11:47:28.670135Z",
 "Status":"IN_SENATE_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2025-01-16","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2025-01-16","Chamber":"SENATE"}],
 "Sponsors":[{"ID":885,"Name":"Robert Ortt","Short":"ORTT"},{"ID":1499,"Name":"Peter Oberacker","Short":"OBERACKER"}],
 "Title":"Prohibits co-pays for certain short term opioid drug prescriptions",
 "Summary":"Prohibits insurance companies from imposing a co-pay pursuant to a follow up visit with a physician in order to receive a refill on an opioid drug prescription which was initially written for seven days or less.",
 "LawSection":"Insurance Law","LawCode":"Amd ยง3216, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to prohibiting insurance companies from imposing a co-pay pursuant to a follow up visit with a physician in order to receive a refill on an opioid drug prescription",
 "SameAsPrintNo":"A5157-2025","PreviousVersions":["S3666-2017","S279-2019","S3497-2021","S790-2023"]
}